AEON Biopharma, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AEON | ABVC | ALGS | ACXP | ANVS | EOCN | |
|---|---|---|---|---|---|---|
| Market cap | 14.92M | 26.69M | 31.35M | 5.64M | 51.64M | 2.96M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.8 | -2.3 | -1.0 | -0.6 | -1.4 | — |
| Price/book | -0.4 | 2.5 | 1.0 | 0.6 | -12.1 | 0.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −79.01% | −64.79% | −29.30% | −80.19% | −39.20% | −71.92% |
| Today | −1.70% | +1.51% | +5.68% | +0.98% | +11.01% | −1.42% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All AEON news ›AEON Biopharma (NASDAQ:AEON) Stock Breaks Above 50-Day Moving Average – Here’s What Happened
Posted by Tristan Rich on Oct 31st, 2026 AEON Biopharma, Inc. (NASDAQ:AEON – Get Free Report)’s stock price passed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of $0.26 and traded…
AEON Biopharma, Inc. Details ABP-450 Biosimilar Strategy and Plans Q4’26 IND Submission
Priveterra Acquisition Corp. II, operating as AEON Biopharma, Inc., disclosed an updated corporate presentation on October 23, 2026, regarding the development of ABP-450 as a potential clinically substitutable therapeutic alternative to…
Certain Common Stock of AEON Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2026.
www.marketscreener.com Certain Common Stock of AEON Biopharma, Inc are subject to a Lock-Up Agreement Ending on 12-OCT-2026 These Common Stock will be under lockup for 90 days starting from 14-JU
Aethlon Medical Expands Authorized Common Stock Capacity
Aethlon Medical ( (AEMD) ) just unveiled an update. At the 2026 Annual Meeting of Stockholders held on October 1, 2026, Aethlon Medical, Inc. shareholders approved an amendment to the company’s Articles of Incorporation to significantly…
Aeon Biopharma Announces Appointment of Paul Lee as Acting Chief Regulatory Officer
AEON Biopharma, Inc. announced the designation of Paul Lee, M.D., Ph.D. as the Company's acting Chief Regulatory Officer, through Clintrex. Dr. Lee and Clintrex currently advised AEON on the... announced the designation of Paul Lee, M.D.,…
Aeon Biopharma, Inc. Appoints John Bencich as the Principal Financial Officer, Effective as of April 1, 2026
AEON Biopharma, Inc. announced that on March 6, 2029, the board of directors of the company appointed John Bencich, age 49, as the principal financial officer, effective as of April 1, 2026. Mr.... announced that on March 6, 2029, the…
AEON Biopharma Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
ALISO VIEJO, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ('AEON” or the 'Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX® (onabotulinumtoxinA) for therapeutic use…
AEON Biopharma, Inc. Elects Each of Marc Forth and Seongsoo Park as Class III Directors of the Company's Board of Directors
AEON Biopharma, Inc. at its Annual Meeting of Stockholders on June 17, 2026 elected each of Marc Forth and Seongsoo Park as Class III directors of the Company?s board of directors for a three-year... Published on 06/17/2026 at 05:05 pm EDT…
Aeon Biopharma Presents Data Demonstrating Structural and Functional Comparability of Abp-450 to Botox At the 68Th Annual Scientific Meeting of the American Headache Society
AEON Biopharma had announced the presentation of new analytical and functional data supporting biosimilarity of ABP-450 to BOTOX at the 68th Annual Scientific Meeting of the American Headache Society,... AEON Biopharma had announced the…
AEON Biopharma, Inc. Auditor Raises 'Going Concern' Doubt
AEON Biopharma, Inc. filed its 10-K on Mar 30, 2026 for the period ending Dec 31, 2025. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing... Biotechnology & Medical Research AEON…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com16
- theglobeandmail.com2
- manilatimes.net1
- nasdaq.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.